Cargando…

A Review of Metabolic Targets of Anticancer Nutrients and Nutraceuticals in Pre-Clinical Models of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is notoriously aggressive and has poorer outcomes as compared with other breast cancer subtypes. Due to a lack of targeted therapies, TNBC is often treated with chemotherapeutics as opposed to hormone therapy or other targeted t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiggs, Alleigh, Molina, Sabrina, Sumner, Susan J., Rushing, Blake R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146055/ https://www.ncbi.nlm.nih.gov/pubmed/35631131 http://dx.doi.org/10.3390/nu14101990

Ejemplares similares

Metabolomics Analysis Reveals Novel Targets of Chemosensitizing Polyphenols and Omega-3 Polyunsaturated Fatty Acids in Triple Negative Breast Cancer Cells
por: Rushing, Blake R., et al.
Publicado: (2023)

Metabolomics Analysis Reveals Altered Metabolic Pathways and Response to Doxorubicin in Drug-Resistant Triple-Negative Breast Cancer Cells
por: Rushing, Blake R., et al.
Publicado: (2023)

Comparison of Lysis and Detachment Sample Preparation Methods for Cultured Triple-Negative Breast Cancer Cells Using UHPLC–HRMS-Based Metabolomics
por: Rushing, Blake R., et al.
Publicado: (2022)

The Effects of Diet and Exercise on Endogenous Estrogens and Subsequent Breast Cancer Risk in Postmenopausal Women
por: Wiggs, Alleigh G., et al.
Publicado: (2021)

Commonalities in Metabolic Reprogramming between Tobacco Use and Oral Cancer
por: Rushing, Blake R., et al.
Publicado: (2022)

Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction
por: Coleman, Michael F., et al.
Publicado: (2021)

Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer
por: Fennell, Emily M. J., et al.
Publicado: (2023)

Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2020)

Nutrients, Nutraceuticals, and Xenobiotics Affecting Renal Health
por: Cosola, Carmela, et al.
Publicado: (2018)

The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
por: Varghese, Elizabeth, et al.
Publicado: (2018)

Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
por: Bahman, Fatemah, et al.
Publicado: (2021)

Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer
por: Wahdan-Alaswad, RS, et al.
Publicado: (2018)

Metabolic characterization of triple negative breast cancer
por: Cao, Maria D, et al.
Publicado: (2014)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2021)

Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer
por: Kwon, Ahreum, et al.
Publicado: (2020)

CSA Antisense Targeting Enhances Anticancer Drug Sensitivity in Breast Cancer Cells, including the Triple-Negative Subtype
por: Filippi, Silvia, et al.
Publicado: (2022)

The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer
por: Ulhaka, Karan, et al.
Publicado: (2021)

Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency
por: Liao, Gaoming, et al.
Publicado: (2022)

Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines
por: Wong, Fu Hou, et al.
Publicado: (2022)

Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
por: Winnike, Jason H., et al.
Publicado: (2018)

Drying the leaves of Perilla frutescens increases their content of anticancer nutraceuticals
por: Kagawa, Natsuko, et al.
Publicado: (2019)

Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model
por: García-Castillo, Verónica, et al.
Publicado: (2017)

Highly Adaptable Triple-Negative Breast Cancer Cells as a Functional Model for Testing Anticancer Agents
por: Singh, Balraj, et al.
Publicado: (2014)

Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy
por: Feng, Tingting, et al.
Publicado: (2016)

Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
por: Jeon, Ye-Won, et al.
Publicado: (2022)

Comparative Investigation of Frankincense Nutraceuticals: Correlation of Boswellic and Lupeolic Acid Contents with Cytokine Release Inhibition and Toxicity against Triple-Negative Breast Cancer Cells
por: Schmiech, Michael, et al.
Publicado: (2019)

Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
por: Lanning, Nathan J., et al.
Publicado: (2017)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

The Anticancer Potential of Plant-Derived Nutraceuticals via the Modulation of Gene Expression
por: Vrânceanu, Maria, et al.
Publicado: (2022)

Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple-negative breast cancer cells
por: LEE, JAEHYUNG, et al.
Publicado: (2013)

Anticancer mechanism of 7-α-hydroxyfrullanolide on microtubules and computational prediction of its target binding in triple-negative breast cancer cells
por: Chimplee, Siriphorn, et al.
Publicado: (2022)

Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer
por: Abduh, Maisa Siddiq
Publicado: (2023)

Plant Sterols as Anticancer Nutrients: Evidence for Their Role in Breast Cancer
por: Grattan, Bruce J.
Publicado: (2013)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells
por: Etti, Imaobong Christopher, et al.
Publicado: (2017)

Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment
por: Barbieri, Antonio, et al.
Publicado: (2017)

SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
por: Choi, Yu-Jeong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g48u6smrafjldmto051iak1ssn